Baroda BNP Paribas Large & Mid Cap Fund
(An open ended scheme investing in both
large cap and mid cap stocks)
Baroda BNP Paribas Large & Mid Cap Fund
(An open ended scheme investing in both
large cap and mid cap stocks)
December 2024

December 2024


Investment Objective

The primary objective of the Scheme is to seek long term capital growth through investments in both large cap and mid cap stocks. However, there can be no assurance that the investment objectives of the Scheme will be realized. The Scheme does not guarantee/indicate any returns.

NAV Details (As on December 31, 2024)
Regular Plan - Growth Option : ₹21.8297
Regular Plan - IDCW Option : ₹27.6099
Direct Plan - Growth Option : ₹24.7597
Direct Plan - IDCW Option : ₹29.4587
Benchmark Index (Tier 1)

BSE 250 Large & Mid Cap TRI

Date of Allotment

September 04, 2020

Fund Manager
Fund Manager Managing fund since Experience
Mr. Sanjay Chawla 04-Sep-20 33 years
Load Structure

Exit Load: Upto 365 days • Redeemed or switched out upto 10% of the allotment: Nil Redeemed or switched out more than 10% of the allotment: 1% After 365 days - Nil For detailed load structure please refer Scheme Information Document of the scheme.


Lumpsum Details

Minimum Application Amount:
₹ 5,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on December 31, 2024 : ₹ 1,540.25 Crores
AUM## As on December 31, 2024 : ₹ 1,539.83 Crores

## excluding inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS% of Net Assets
Banks 16.40%
HDFC Bank Limited 6.04%
ICICI Bank Limited 4.16%
The Federal Bank Limited 2.92%
Bank of Baroda 2.19%
AU Small Finance Bank Limited 1.09%
IT - Software 9.80%
Infosys Limited 4.40%
Mphasis Limited 2.31%
Tata Consultancy Services Limited 1.86%
Wipro Limited 1.23%
Finance 8.40%
CRISIL Limited 3.46%
PNB Housing Finance Limited 2.50%
Shriram Finance Limited 2.44%
Pharmaceuticals & Biotechnology 7.77%
Concord Biotech Limited 2.37%
Alkem Laboratories Limited 2.01%
Ajanta Pharma Limited 2.00%
Divi's Laboratories Limited 1.39%
Petroleum Products 6.44%
Reliance Industries Limited 3.79%
Hindustan Petroleum Corporation Limited 2.65%
Consumer Durables 5.23%
Dixon Technologies (India) Limited 3.49%
Blue Star Limited 1.74%
Electrical Equipment 4.82%
GE Vernova T&D India Limited 2.41%
ABB India Limited 1.35%
Siemens Limited 1.06%
Retailing 4.28%
FSN E-Commerce Ventures Limited 1.54%
Trent Limited 1.39%
Zomato Limited 1.35%
Financial Technology (Fintech) 4.11%
PB Fintech Limited 4.11%
Auto Components 3.86%
Sona BLW Precision Forgings Limited 1.74%
ZF Commercial Vehicle Control Systems India Limited 1.17%
Motherson Sumi Wiring India Limited 0.95%
Power 3.36%
NTPC Green Energy Limited 1.76%
Power Grid Corporation of India Limited 1.60%
Capital Markets 2.47%
Computer Age Management Services Limited 2.47%
Industrial Manufacturing 2.17%
Kaynes Technology India Limited 2.17%
Textiles & Apparels 2.16%
Page Industries Limited 2.16%
Insurance 1.81%
Max Financial Services Limited 1.81%
Leisure Services 1.42%
The Indian Hotels Company Limited 1.42%
Oil 1.40%
Oil India Limited 1.40%
Construction 1.34%
Larsen & Toubro Limited 1.34%
Telecom - Services 1.29%
Bharti Airtel Limited 1.29%
Transport Services 1.26%
InterGlobe Aviation Limited 1.26%
Healthcare Services 1.22%
Jupiter Life Line Hospitals Limited 1.22%
Agricultural, Commercial & Construction Vehicles 1.19%
Escorts Kubota Limited 1.19%
Personal Products 0.95%
Godrej Consumer Products Limited 0.95%
LESS THAN 0.75% EXPOSURE 2.99%
TOTAL EQUITY HOLDING 96.14%
Total Fixed Income Holdings
TREPS, Cash & Other Net Current Assets 3.86%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 37.52% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here

The scheme currently does not have a Distribution track record.


Pursuant to distribution under Income Distribution cum Capital Withdrawal (‘IDCW’) option, NAV of the IDCW option of the scheme(s) would fall to the extent of payout and statutory levy (if applicable). The amounts under IDCW options can be distributed out of investors capital (Equalization Reserve), which is part of sale price that represents realized gains. Past performance may or may not be sustained in future. The above stated distribution rate per unit is net distribution rate after deducting applicable taxes. The above distribution rates are on face value of ₹ 10 per unit.

TER - Regular Plan (%) 2.11%
TER - Direct Plan (%) 0.83%
Portfolio Turnover Ratio 0.94
Standard Deviation* 14.09%
Beta* 0.96
Sharpe Ratio* 0.75

* The information contained in this report has been obtained from sources considered to be authentic and reliable. This quantitative data does not purport to be an offer for purchase and sale of mutual fund units. The risk free rate of return considered for calculation of Sharpe ratio is 7.15%, as per 1 day MIBOR rate on the last business day of the month.

No of Stocks 49
Portfolio RoE (%) 18.03
EPS Growth (%) 37.7

Portfolio RoE and EPS Growth is for trailing 12 months (TTM) whereas the number of stocks is as of December 31, 2024.
This product is suitable for investors who are seeking*:

➤ Capital appreciation over long term.
➤ Investment predominantly in equity and equity related instruments of large and midcap stocks.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (BSE 250 Large & Mid Cap TRI): basis it’s constituents; As on December 31, 2024

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.